Nicole Annette Shonka MD

Hematologic Oncology, Neuro-Oncology

Assistant Professor, Internal Medicine, University of Nebraska Medical Center College of Medicine

988102 Nebraska Medical CtrOmaha, NE 68198
Phone+1 402-559-9800
Fax+1 402-559-6520

Dr. Shonka is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Shonka's full profile Already have an account?

Education & Training

University of Texas M D Anderson Cancer CenterFellowship, Neuro-Oncology, 2009 - 2010
University of Nebraska Medical Center College of MedicineFellowship, Hematology and Medical Oncology, 2007 - 2009
University of Nebraska Medical Center College of MedicineResidency, Internal Medicine, 2002 - 2005
University of Nebraska College of MedicineClass of 2002

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

IA State Medical License 2015 - 2027
NE State Medical License 2004 - 2026
CO State Medical License 2005 - 2007
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2013-2014, 2016-2017
CMS Meaningful Use Stage 1 Certification EpicCare Inpatient - Core EMR, Epic Systems Corporation, 2013-2014, 2016-2017
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2014, 2016-2017

Clinical Trials

Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma
ACTIVE_NOT_RECRUITING
PHASE3
Biomarkers for Prognosis of Glioblastoma (GBM) Start of enrollment: 2011 Sep 20
COMPLETED
Vaccine Therapy With Bevacizumab Versus Bevacizumab Alone in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery Start of enrollment: 2013 Jun 19
TERMINATED
PHASE2

Publications & Presentations

PubMed

Nerve growth factor receptor (NGFR): A key player in glioblastoma progression.
Blake M Kidder, Raghupathy Vengoji, Surinder K Batra, Nicole Shonka
Biochimica Et Biophysica Acta. Reviews on Cancer. 2026-09-01
Abexinostat attenuates temozolomide-resistant glioma stem cells.
Balaji Perumalsamy, Raghupathy Vengoji, Anand Thiraviyam, Indumati Ramireddy, Poonam Yadav
Neuro-Oncology. 2026-08-19
Malignant craniopharyngiomas: Institutional experience and literature review.
Thomas J Auen, Isabella W Zhang, Weiwei Zhang, Jordan M Burr, Matthew L Carda
Brain Pathology. 2026-07-01

Press Mentions

Gene Mutation Defines Brain Tumors That Benefit from Aggressive SurgeryFebruary 3rd, 2014
Medical Research Highlights, February 2024February 14th, 2024